nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—GABRG3—autistic disorder	0.166	0.216	CbGaD
Quazepam—GABRB1—autistic disorder	0.124	0.161	CbGaD
Quazepam—GABRA5—autistic disorder	0.103	0.134	CbGaD
Quazepam—GABRB3—autistic disorder	0.103	0.134	CbGaD
Quazepam—GABRA3—autistic disorder	0.101	0.131	CbGaD
Quazepam—GABRA1—autistic disorder	0.0882	0.115	CbGaD
Quazepam—GABRA2—autistic disorder	0.0843	0.11	CbGaD
Quazepam—GABRR3—eye—autistic disorder	0.0016	0.0276	CbGeAlD
Quazepam—GABRP—mouth—autistic disorder	0.00153	0.0263	CbGeAlD
Quazepam—GABRR2—eye—autistic disorder	0.00139	0.024	CbGeAlD
Quazepam—GABRA2—hindbrain—autistic disorder	0.00134	0.0231	CbGeAlD
Quazepam—GABRR1—eye—autistic disorder	0.00134	0.0231	CbGeAlD
Quazepam—GABRR1—forebrain—autistic disorder	0.00133	0.0229	CbGeAlD
Quazepam—GABRA1—hindbrain—autistic disorder	0.0013	0.0223	CbGeAlD
Quazepam—GABRD—forebrain—autistic disorder	0.00115	0.0199	CbGeAlD
Quazepam—GABRG1—forebrain—autistic disorder	0.00111	0.0191	CbGeAlD
Quazepam—GABRA5—forebrain—autistic disorder	0.00107	0.0184	CbGeAlD
Quazepam—GABRD—telencephalon—autistic disorder	0.00106	0.0183	CbGeAlD
Quazepam—GABRG1—telencephalon—autistic disorder	0.00102	0.0176	CbGeAlD
Quazepam—GABRB1—telencephalon—autistic disorder	0.000989	0.017	CbGeAlD
Quazepam—GABRA5—telencephalon—autistic disorder	0.000984	0.017	CbGeAlD
Quazepam—GABRR3—head—autistic disorder	0.00091	0.0157	CbGeAlD
Quazepam—GABRR3—nervous system—autistic disorder	0.000862	0.0149	CbGeAlD
Quazepam—GABRG2—forebrain—autistic disorder	0.000812	0.014	CbGeAlD
Quazepam—GABRG3—head—autistic disorder	0.000797	0.0137	CbGeAlD
Quazepam—GABRR2—head—autistic disorder	0.000789	0.0136	CbGeAlD
Quazepam—GABRA2—brainstem—autistic disorder	0.000768	0.0132	CbGeAlD
Quazepam—GABRR1—head—autistic disorder	0.000759	0.0131	CbGeAlD
Quazepam—GABRG3—nervous system—autistic disorder	0.000755	0.013	CbGeAlD
Quazepam—GABRR2—nervous system—autistic disorder	0.000748	0.0129	CbGeAlD
Quazepam—GABRG2—telencephalon—autistic disorder	0.000746	0.0129	CbGeAlD
Quazepam—GABRA1—brainstem—autistic disorder	0.000743	0.0128	CbGeAlD
Quazepam—GABRA2—forebrain—autistic disorder	0.000742	0.0128	CbGeAlD
Quazepam—GABRG3—central nervous system—autistic disorder	0.000727	0.0125	CbGeAlD
Quazepam—GABRR1—nervous system—autistic disorder	0.00072	0.0124	CbGeAlD
Quazepam—GABRA1—forebrain—autistic disorder	0.000717	0.0124	CbGeAlD
Quazepam—GABRR2—cerebellum—autistic disorder	0.000704	0.0121	CbGeAlD
Quazepam—GABRR1—central nervous system—autistic disorder	0.000693	0.0119	CbGeAlD
Quazepam—GABRA2—telencephalon—autistic disorder	0.000682	0.0118	CbGeAlD
Quazepam—GABRD—head—autistic disorder	0.00066	0.0114	CbGeAlD
Quazepam—GABRA1—telencephalon—autistic disorder	0.000659	0.0114	CbGeAlD
Quazepam—GABRG1—head—autistic disorder	0.000635	0.0109	CbGeAlD
Quazepam—GABRB3—eye—autistic disorder	0.000629	0.0108	CbGeAlD
Quazepam—GABRD—nervous system—autistic disorder	0.000625	0.0108	CbGeAlD
Quazepam—GABRB3—forebrain—autistic disorder	0.000623	0.0107	CbGeAlD
Quazepam—GABRB1—head—autistic disorder	0.000616	0.0106	CbGeAlD
Quazepam—GABRA5—head—autistic disorder	0.000612	0.0106	CbGeAlD
Quazepam—GABRD—central nervous system—autistic disorder	0.000602	0.0104	CbGeAlD
Quazepam—GABRG1—nervous system—autistic disorder	0.000602	0.0104	CbGeAlD
Quazepam—GABRD—cerebellum—autistic disorder	0.000589	0.0101	CbGeAlD
Quazepam—GABRB1—nervous system—autistic disorder	0.000584	0.0101	CbGeAlD
Quazepam—GABRA5—nervous system—autistic disorder	0.000581	0.01	CbGeAlD
Quazepam—GABRG1—central nervous system—autistic disorder	0.00058	0.00999	CbGeAlD
Quazepam—GABRG3—brain—autistic disorder	0.000577	0.00995	CbGeAlD
Quazepam—GABRB3—telencephalon—autistic disorder	0.000573	0.00988	CbGeAlD
Quazepam—GABRA3—head—autistic disorder	0.00057	0.00983	CbGeAlD
Quazepam—GABRG1—cerebellum—autistic disorder	0.000567	0.00977	CbGeAlD
Quazepam—GABRB1—central nervous system—autistic disorder	0.000562	0.00969	CbGeAlD
Quazepam—GABRA5—central nervous system—autistic disorder	0.000559	0.00964	CbGeAlD
Quazepam—GABRP—head—autistic disorder	0.000552	0.00951	CbGeAlD
Quazepam—GABRR1—brain—autistic disorder	0.00055	0.00948	CbGeAlD
Quazepam—GABRB1—cerebellum—autistic disorder	0.000549	0.00947	CbGeAlD
Quazepam—GABRA3—nervous system—autistic disorder	0.000541	0.00932	CbGeAlD
Quazepam—GABRA3—central nervous system—autistic disorder	0.00052	0.00897	CbGeAlD
Quazepam—GABRD—brain—autistic disorder	0.000478	0.00824	CbGeAlD
Quazepam—GABRG2—head—autistic disorder	0.000465	0.00801	CbGeAlD
Quazepam—GABRG1—brain—autistic disorder	0.00046	0.00793	CbGeAlD
Quazepam—GABRB1—brain—autistic disorder	0.000446	0.00769	CbGeAlD
Quazepam—GABRA5—brain—autistic disorder	0.000444	0.00765	CbGeAlD
Quazepam—GABRG2—nervous system—autistic disorder	0.000441	0.0076	CbGeAlD
Quazepam—GABRA2—head—autistic disorder	0.000425	0.00732	CbGeAlD
Quazepam—GABRG2—central nervous system—autistic disorder	0.000424	0.00731	CbGeAlD
Quazepam—GABRE—head—autistic disorder	0.000421	0.00726	CbGeAlD
Quazepam—GABRG2—cerebellum—autistic disorder	0.000415	0.00715	CbGeAlD
Quazepam—GABRA3—brain—autistic disorder	0.000413	0.00712	CbGeAlD
Quazepam—GABRA1—head—autistic disorder	0.00041	0.00708	CbGeAlD
Quazepam—GABRA2—nervous system—autistic disorder	0.000403	0.00694	CbGeAlD
Quazepam—GABRE—nervous system—autistic disorder	0.000399	0.00688	CbGeAlD
Quazepam—GABRA1—nervous system—autistic disorder	0.000389	0.00671	CbGeAlD
Quazepam—GABRA2—central nervous system—autistic disorder	0.000388	0.00668	CbGeAlD
Quazepam—GABRE—central nervous system—autistic disorder	0.000384	0.00663	CbGeAlD
Quazepam—CYP2C19—digestive system—autistic disorder	0.000379	0.00653	CbGeAlD
Quazepam—GABRA2—cerebellum—autistic disorder	0.000379	0.00653	CbGeAlD
Quazepam—GABRA1—central nervous system—autistic disorder	0.000375	0.00646	CbGeAlD
Quazepam—GABRA1—cerebellum—autistic disorder	0.000366	0.00631	CbGeAlD
Quazepam—GABRB3—head—autistic disorder	0.000357	0.00615	CbGeAlD
Quazepam—GABRB3—nervous system—autistic disorder	0.000338	0.00583	CbGeAlD
Quazepam—GABRG2—brain—autistic disorder	0.000337	0.00581	CbGeAlD
Quazepam—GABRB3—central nervous system—autistic disorder	0.000326	0.00562	CbGeAlD
Quazepam—GABRB3—cerebellum—autistic disorder	0.000318	0.00549	CbGeAlD
Quazepam—GABRA2—brain—autistic disorder	0.000308	0.00531	CbGeAlD
Quazepam—GABRE—brain—autistic disorder	0.000305	0.00526	CbGeAlD
Quazepam—GABRA1—brain—autistic disorder	0.000297	0.00513	CbGeAlD
Quazepam—CYP2C9—digestive system—autistic disorder	0.000294	0.00506	CbGeAlD
Quazepam—GABRB3—brain—autistic disorder	0.000259	0.00446	CbGeAlD
Quazepam—CYP3A4—digestive system—autistic disorder	0.000224	0.00386	CbGeAlD
Quazepam—CYP3A4—nervous system—autistic disorder	0.000173	0.00299	CbGeAlD
Quazepam—CYP3A4—central nervous system—autistic disorder	0.000167	0.00288	CbGeAlD
Quazepam—Clotiazepam—GABRG3—autistic disorder	0.000134	0.017	CrCbGaD
Quazepam—Cinolazepam—GABRG3—autistic disorder	0.000124	0.0156	CrCbGaD
Quazepam—Estazolam—GABRG3—autistic disorder	0.000109	0.0137	CrCbGaD
Quazepam—Lorazepam—GABRB3—autistic disorder	0.000107	0.0135	CrCbGaD
Quazepam—Halazepam—GABRG3—autistic disorder	0.000105	0.0134	CrCbGaD
Quazepam—Adinazolam—GABRG3—autistic disorder	0.000103	0.0131	CrCbGaD
Quazepam—Fludiazepam—GABRG3—autistic disorder	0.000102	0.013	CrCbGaD
Quazepam—Clotiazepam—GABRB1—autistic disorder	0.0001	0.0127	CrCbGaD
Quazepam—Prazepam—GABRG3—autistic disorder	9.99e-05	0.0126	CrCbGaD
Quazepam—Flurazepam—GABRG3—autistic disorder	9.32e-05	0.0118	CrCbGaD
Quazepam—Triazolam—GABRG3—autistic disorder	9.31e-05	0.0118	CrCbGaD
Quazepam—Cinolazepam—GABRB1—autistic disorder	9.22e-05	0.0117	CrCbGaD
Quazepam—Lorazepam—GABRA1—autistic disorder	9.15e-05	0.0116	CrCbGaD
Quazepam—Temazepam—GABRG3—autistic disorder	8.91e-05	0.0113	CrCbGaD
Quazepam—Clonazepam—GABRA3—autistic disorder	8.8e-05	0.0111	CrCbGaD
Quazepam—Midazolam—GABRG3—autistic disorder	8.64e-05	0.0109	CrCbGaD
Quazepam—Clotiazepam—GABRB3—autistic disorder	8.32e-05	0.0105	CrCbGaD
Quazepam—Clotiazepam—GABRA5—autistic disorder	8.32e-05	0.0105	CrCbGaD
Quazepam—Clotiazepam—GABRA3—autistic disorder	8.17e-05	0.0103	CrCbGaD
Quazepam—Estazolam—GABRB1—autistic disorder	8.11e-05	0.0103	CrCbGaD
Quazepam—Flunitrazepam—GABRA4—autistic disorder	8.1e-05	0.0102	CrCbGaD
Quazepam—Halazepam—GABRB1—autistic disorder	7.88e-05	0.00997	CrCbGaD
Quazepam—Alprazolam—GABRA5—autistic disorder	7.86e-05	0.00995	CrCbGaD
Quazepam—Alprazolam—GABRB3—autistic disorder	7.86e-05	0.00995	CrCbGaD
Quazepam—Clonazepam—GABRB2—autistic disorder	7.84e-05	0.00993	CrCbGaD
Quazepam—Adinazolam—GABRB1—autistic disorder	7.72e-05	0.00977	CrCbGaD
Quazepam—Alprazolam—GABRA3—autistic disorder	7.72e-05	0.00977	CrCbGaD
Quazepam—Clonazepam—GABRA1—autistic disorder	7.69e-05	0.00974	CrCbGaD
Quazepam—Cinolazepam—GABRA5—autistic disorder	7.66e-05	0.00969	CrCbGaD
Quazepam—Cinolazepam—GABRB3—autistic disorder	7.66e-05	0.00969	CrCbGaD
Quazepam—Fludiazepam—GABRB1—autistic disorder	7.64e-05	0.00967	CrCbGaD
Quazepam—Cinolazepam—GABRA3—autistic disorder	7.52e-05	0.00952	CrCbGaD
Quazepam—Prazepam—GABRB1—autistic disorder	7.46e-05	0.00944	CrCbGaD
Quazepam—Diazepam—GABRG3—autistic disorder	7.4e-05	0.00937	CrCbGaD
Quazepam—Halazepam—GABRA4—autistic disorder	7.36e-05	0.00931	CrCbGaD
Quazepam—Clotiazepam—GABRB2—autistic disorder	7.28e-05	0.00922	CrCbGaD
Quazepam—Adinazolam—GABRA4—autistic disorder	7.21e-05	0.00912	CrCbGaD
Quazepam—Flunitrazepam—GABRA5—autistic disorder	7.19e-05	0.00911	CrCbGaD
Quazepam—Clotiazepam—GABRA1—autistic disorder	7.14e-05	0.00904	CrCbGaD
Quazepam—Flunitrazepam—GABRA3—autistic disorder	7.06e-05	0.00894	CrCbGaD
Quazepam—Flurazepam—GABRB1—autistic disorder	6.96e-05	0.0088	CrCbGaD
Quazepam—Triazolam—GABRB1—autistic disorder	6.95e-05	0.00879	CrCbGaD
Quazepam—Alprazolam—GABRB2—autistic disorder	6.88e-05	0.0087	CrCbGaD
Quazepam—Clotiazepam—GABRA2—autistic disorder	6.83e-05	0.00864	CrCbGaD
Quazepam—Alprazolam—GABRA1—autistic disorder	6.74e-05	0.00854	CrCbGaD
Quazepam—Estazolam—GABRB3—autistic disorder	6.73e-05	0.00852	CrCbGaD
Quazepam—Estazolam—GABRA5—autistic disorder	6.73e-05	0.00852	CrCbGaD
Quazepam—Cinolazepam—GABRB2—autistic disorder	6.7e-05	0.00848	CrCbGaD
Quazepam—Temazepam—GABRB1—autistic disorder	6.65e-05	0.00842	CrCbGaD
Quazepam—Estazolam—GABRA3—autistic disorder	6.61e-05	0.00836	CrCbGaD
Quazepam—Cinolazepam—GABRA1—autistic disorder	6.57e-05	0.00832	CrCbGaD
Quazepam—Halazepam—GABRA5—autistic disorder	6.54e-05	0.00828	CrCbGaD
Quazepam—Halazepam—GABRB3—autistic disorder	6.54e-05	0.00828	CrCbGaD
Quazepam—Flurazepam—GABRA4—autistic disorder	6.5e-05	0.00823	CrCbGaD
Quazepam—Triazolam—GABRA4—autistic disorder	6.49e-05	0.00822	CrCbGaD
Quazepam—Midazolam—GABRB1—autistic disorder	6.45e-05	0.00816	CrCbGaD
Quazepam—Alprazolam—GABRA2—autistic disorder	6.45e-05	0.00816	CrCbGaD
Quazepam—Halazepam—GABRA3—autistic disorder	6.42e-05	0.00813	CrCbGaD
Quazepam—Adinazolam—GABRA5—autistic disorder	6.4e-05	0.00811	CrCbGaD
Quazepam—Adinazolam—GABRB3—autistic disorder	6.4e-05	0.00811	CrCbGaD
Quazepam—Fludiazepam—GABRA5—autistic disorder	6.34e-05	0.00803	CrCbGaD
Quazepam—Fludiazepam—GABRB3—autistic disorder	6.34e-05	0.00803	CrCbGaD
Quazepam—Adinazolam—GABRA3—autistic disorder	6.29e-05	0.00796	CrCbGaD
Quazepam—Cinolazepam—GABRA2—autistic disorder	6.28e-05	0.00795	CrCbGaD
Quazepam—Fludiazepam—GABRA3—autistic disorder	6.23e-05	0.00789	CrCbGaD
Quazepam—Temazepam—GABRA4—autistic disorder	6.21e-05	0.00786	CrCbGaD
Quazepam—Prazepam—GABRA5—autistic disorder	6.19e-05	0.00784	CrCbGaD
Quazepam—Prazepam—GABRB3—autistic disorder	6.19e-05	0.00784	CrCbGaD
Quazepam—Flunitrazepam—GABRA1—autistic disorder	6.17e-05	0.00782	CrCbGaD
Quazepam—Prazepam—GABRA3—autistic disorder	6.08e-05	0.0077	CrCbGaD
Quazepam—Midazolam—GABRA4—autistic disorder	6.02e-05	0.00763	CrCbGaD
Quazepam—Flunitrazepam—GABRA2—autistic disorder	5.9e-05	0.00747	CrCbGaD
Quazepam—Estazolam—GABRB2—autistic disorder	5.89e-05	0.00745	CrCbGaD
Quazepam—Estazolam—GABRA1—autistic disorder	5.78e-05	0.00731	CrCbGaD
Quazepam—Flurazepam—GABRB3—autistic disorder	5.77e-05	0.00731	CrCbGaD
Quazepam—Flurazepam—GABRA5—autistic disorder	5.77e-05	0.00731	CrCbGaD
Quazepam—Triazolam—GABRB3—autistic disorder	5.77e-05	0.0073	CrCbGaD
Quazepam—Triazolam—GABRA5—autistic disorder	5.77e-05	0.0073	CrCbGaD
Quazepam—Halazepam—GABRB2—autistic disorder	5.72e-05	0.00724	CrCbGaD
Quazepam—Flurazepam—GABRA3—autistic disorder	5.67e-05	0.00718	CrCbGaD
Quazepam—Triazolam—GABRA3—autistic disorder	5.66e-05	0.00717	CrCbGaD
Quazepam—Halazepam—GABRA1—autistic disorder	5.61e-05	0.0071	CrCbGaD
Quazepam—Adinazolam—GABRB2—autistic disorder	5.61e-05	0.0071	CrCbGaD
Quazepam—Fludiazepam—GABRB2—autistic disorder	5.55e-05	0.00703	CrCbGaD
Quazepam—Diazepam—GABRB1—autistic disorder	5.53e-05	0.00699	CrCbGaD
Quazepam—Estazolam—GABRA2—autistic disorder	5.52e-05	0.00699	CrCbGaD
Quazepam—Temazepam—GABRA5—autistic disorder	5.52e-05	0.00699	CrCbGaD
Quazepam—Temazepam—GABRB3—autistic disorder	5.52e-05	0.00699	CrCbGaD
Quazepam—Adinazolam—GABRA1—autistic disorder	5.5e-05	0.00696	CrCbGaD
Quazepam—Fludiazepam—GABRA1—autistic disorder	5.45e-05	0.00689	CrCbGaD
Quazepam—Temazepam—GABRA3—autistic disorder	5.42e-05	0.00686	CrCbGaD
Quazepam—Prazepam—GABRB2—autistic disorder	5.42e-05	0.00686	CrCbGaD
Quazepam—Halazepam—GABRA2—autistic disorder	5.36e-05	0.00679	CrCbGaD
Quazepam—Midazolam—GABRA5—autistic disorder	5.35e-05	0.00678	CrCbGaD
Quazepam—Midazolam—GABRB3—autistic disorder	5.35e-05	0.00678	CrCbGaD
Quazepam—Prazepam—GABRA1—autistic disorder	5.32e-05	0.00673	CrCbGaD
Quazepam—Midazolam—GABRA3—autistic disorder	5.26e-05	0.00665	CrCbGaD
Quazepam—Adinazolam—GABRA2—autistic disorder	5.26e-05	0.00665	CrCbGaD
Quazepam—Fludiazepam—GABRA2—autistic disorder	5.21e-05	0.00659	CrCbGaD
Quazepam—Prazepam—GABRA2—autistic disorder	5.08e-05	0.00643	CrCbGaD
Quazepam—Flurazepam—GABRB2—autistic disorder	5.05e-05	0.0064	CrCbGaD
Quazepam—Triazolam—GABRB2—autistic disorder	5.05e-05	0.00639	CrCbGaD
Quazepam—Flurazepam—GABRA1—autistic disorder	4.96e-05	0.00627	CrCbGaD
Quazepam—Triazolam—GABRA1—autistic disorder	4.95e-05	0.00627	CrCbGaD
Quazepam—Temazepam—GABRB2—autistic disorder	4.83e-05	0.00612	CrCbGaD
Quazepam—Temazepam—GABRA1—autistic disorder	4.74e-05	0.006	CrCbGaD
Quazepam—Flurazepam—GABRA2—autistic disorder	4.74e-05	0.006	CrCbGaD
Quazepam—Triazolam—GABRA2—autistic disorder	4.73e-05	0.00599	CrCbGaD
Quazepam—Midazolam—GABRB2—autistic disorder	4.69e-05	0.00593	CrCbGaD
Quazepam—Midazolam—GABRA1—autistic disorder	4.59e-05	0.00582	CrCbGaD
Quazepam—Diazepam—GABRB3—autistic disorder	4.59e-05	0.00581	CrCbGaD
Quazepam—Diazepam—GABRA5—autistic disorder	4.59e-05	0.00581	CrCbGaD
Quazepam—Temazepam—GABRA2—autistic disorder	4.53e-05	0.00573	CrCbGaD
Quazepam—Diazepam—GABRA3—autistic disorder	4.5e-05	0.0057	CrCbGaD
Quazepam—Midazolam—GABRA2—autistic disorder	4.39e-05	0.00556	CrCbGaD
Quazepam—Diazepam—GABRB2—autistic disorder	4.01e-05	0.00508	CrCbGaD
Quazepam—Diazepam—GABRA1—autistic disorder	3.94e-05	0.00498	CrCbGaD
Quazepam—Diazepam—GABRA2—autistic disorder	3.76e-05	0.00476	CrCbGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—TF—autistic disorder	1.4e-05	8.44e-05	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.38e-05	8.31e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—TF—autistic disorder	1.37e-05	8.29e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—CP—autistic disorder	1.36e-05	8.17e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—TF—autistic disorder	1.35e-05	8.14e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—TF—autistic disorder	1.34e-05	8.09e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—TF—autistic disorder	1.32e-05	7.94e-05	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—PRKCB—autistic disorder	1.32e-05	7.94e-05	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.31e-05	7.92e-05	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	1.3e-05	7.83e-05	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—PRKCB—autistic disorder	1.29e-05	7.79e-05	CbGpPWpGaD
Quazepam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—autistic disorder	1.28e-05	7.73e-05	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—PRKCB—autistic disorder	1.27e-05	7.66e-05	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—PRKCB—autistic disorder	1.26e-05	7.61e-05	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—CYP19A1—autistic disorder	1.24e-05	7.49e-05	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—PRKCB—autistic disorder	1.24e-05	7.47e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—MAOB—autistic disorder	1.23e-05	7.43e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—CYP19A1—autistic disorder	1.23e-05	7.39e-05	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—AVP—autistic disorder	1.19e-05	7.15e-05	CbGpPWpGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.18e-05	7.1e-05	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—AVP—autistic disorder	1.17e-05	7.05e-05	CbGpPWpGaD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.16e-05	6.97e-05	CbGpPWpGaD
Quazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.16e-05	6.97e-05	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—COMT—autistic disorder	1.16e-05	6.96e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—TF—autistic disorder	1.15e-05	6.94e-05	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—GSTP1—autistic disorder	1.15e-05	6.93e-05	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—MAOA—autistic disorder	1.15e-05	6.91e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—COMT—autistic disorder	1.14e-05	6.87e-05	CbGpPWpGaD
Quazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.14e-05	6.86e-05	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.14e-05	6.85e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—GSTP1—autistic disorder	1.13e-05	6.84e-05	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—CYP19A1—autistic disorder	1.13e-05	6.83e-05	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.13e-05	6.81e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—CYP19A1—autistic disorder	1.12e-05	6.74e-05	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	1.11e-05	6.68e-05	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—HRAS—autistic disorder	1.11e-05	6.67e-05	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—MAPK1—autistic disorder	1.1e-05	6.65e-05	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—PRKCB—autistic disorder	1.08e-05	6.53e-05	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.08e-05	6.53e-05	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.07e-05	6.43e-05	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—GSTM1—autistic disorder	1.06e-05	6.37e-05	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—MAPK1—autistic disorder	1.06e-05	6.36e-05	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—HRAS—autistic disorder	1.06e-05	6.36e-05	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—COMT—autistic disorder	1.05e-05	6.35e-05	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTP1—autistic disorder	1.05e-05	6.32e-05	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—MAOA—autistic disorder	1.05e-05	6.3e-05	CbGpPWpGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	1.04e-05	6.29e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—GSTM1—autistic disorder	1.04e-05	6.28e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—COMT—autistic disorder	1.04e-05	6.26e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—GSTP1—autistic disorder	1.03e-05	6.23e-05	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—MAPK1—autistic disorder	1.01e-05	6.07e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	1e-05	6.03e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ACADSB—autistic disorder	9.89e-06	5.96e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—INPP1—autistic disorder	9.89e-06	5.96e-05	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—AVP—autistic disorder	9.71e-06	5.85e-05	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—autistic disorder	9.69e-06	5.84e-05	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTM1—autistic disorder	9.64e-06	5.81e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—AVP—autistic disorder	9.53e-06	5.74e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—GSTM1—autistic disorder	9.5e-06	5.73e-05	CbGpPWpGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	9.46e-06	5.7e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—AVP—autistic disorder	9.37e-06	5.64e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—AVP—autistic disorder	9.3e-06	5.61e-05	CbGpPWpGaD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	9.29e-06	5.6e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—AVP—autistic disorder	9.14e-06	5.51e-05	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	9.12e-06	5.5e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	9.12e-06	5.5e-05	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	9.07e-06	5.46e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ACADSB—autistic disorder	9.02e-06	5.43e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—INPP1—autistic disorder	9.02e-06	5.43e-05	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	8.9e-06	5.36e-05	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—HRAS—autistic disorder	8.86e-06	5.34e-05	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—autistic disorder	8.85e-06	5.34e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—BTD—autistic disorder	8.81e-06	5.31e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—autistic disorder	8.69e-06	5.24e-05	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—HRAS—autistic disorder	8.69e-06	5.24e-05	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—HRAS—autistic disorder	8.56e-06	5.16e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—autistic disorder	8.54e-06	5.15e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—autistic disorder	8.49e-06	5.12e-05	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—HRAS—autistic disorder	8.48e-06	5.11e-05	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	8.46e-06	5.1e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—RORA—autistic disorder	8.41e-06	5.07e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—autistic disorder	8.34e-06	5.02e-05	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—MAPK1—autistic disorder	8.3e-06	5e-05	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—MAPK1—autistic disorder	8.17e-06	4.92e-05	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—HRAS—autistic disorder	8.09e-06	4.87e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—BTD—autistic disorder	8.04e-06	4.84e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—AVP—autistic disorder	7.99e-06	4.81e-05	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	7.78e-06	4.69e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—RORA—autistic disorder	7.67e-06	4.62e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TDO2—autistic disorder	7.49e-06	4.52e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	7.47e-06	4.5e-05	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—POMC—autistic disorder	7.47e-06	4.5e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	7.37e-06	4.44e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—autistic disorder	7.29e-06	4.39e-05	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—HRAS—autistic disorder	7.11e-06	4.28e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DHCR7—autistic disorder	7.05e-06	4.25e-05	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—HRAS—autistic disorder	6.98e-06	4.21e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—COMT—autistic disorder	6.95e-06	4.19e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTP1—autistic disorder	6.92e-06	4.17e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—MAOA—autistic disorder	6.9e-06	4.16e-05	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—HRAS—autistic disorder	6.86e-06	4.13e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	6.85e-06	4.13e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TDO2—autistic disorder	6.83e-06	4.12e-05	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL6—autistic disorder	6.83e-06	4.12e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	6.82e-06	4.11e-05	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—HRAS—autistic disorder	6.81e-06	4.11e-05	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—POMC—autistic disorder	6.81e-06	4.1e-05	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—MAPK1—autistic disorder	6.78e-06	4.09e-05	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—HRAS—autistic disorder	6.69e-06	4.03e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—EXT1—autistic disorder	6.68e-06	4.02e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLC6A8—autistic disorder	6.68e-06	4.02e-05	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—MAPK1—autistic disorder	6.66e-06	4.01e-05	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—HRAS—autistic disorder	6.66e-06	4.01e-05	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—HRAS—autistic disorder	6.56e-06	3.95e-05	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—MAPK1—autistic disorder	6.55e-06	3.95e-05	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—MAPK1—autistic disorder	6.5e-06	3.92e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DHCR7—autistic disorder	6.42e-06	3.87e-05	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—MAPK1—autistic disorder	6.39e-06	3.85e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DAO—autistic disorder	6.37e-06	3.84e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTM1—autistic disorder	6.36e-06	3.83e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	6.27e-06	3.78e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—UPB1—autistic disorder	6.11e-06	3.68e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—EXT1—autistic disorder	6.09e-06	3.67e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLC6A8—autistic disorder	6.09e-06	3.67e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—INPP1—autistic disorder	5.95e-06	3.58e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ACADSB—autistic disorder	5.95e-06	3.58e-05	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—HRAS—autistic disorder	5.85e-06	3.53e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DAO—autistic disorder	5.81e-06	3.5e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ASMT—autistic disorder	5.68e-06	3.42e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTM5—autistic disorder	5.68e-06	3.42e-05	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—MAPK1—autistic disorder	5.58e-06	3.36e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—UPB1—autistic disorder	5.57e-06	3.36e-05	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—HRAS—autistic disorder	5.45e-06	3.28e-05	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—HRAS—autistic disorder	5.35e-06	3.22e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLC25A12—autistic disorder	5.34e-06	3.22e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—BTD—autistic disorder	5.3e-06	3.19e-05	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—HRAS—autistic disorder	5.26e-06	3.17e-05	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—HRAS—autistic disorder	5.22e-06	3.15e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SLC19A1—autistic disorder	5.19e-06	3.13e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ASMT—autistic disorder	5.18e-06	3.12e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTM5—autistic disorder	5.18e-06	3.12e-05	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—HRAS—autistic disorder	5.13e-06	3.09e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLC25A12—autistic disorder	4.87e-06	2.93e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	4.77e-06	2.88e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SLC19A1—autistic disorder	4.74e-06	2.85e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ADSL—autistic disorder	4.63e-06	2.79e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—XDH—autistic disorder	4.54e-06	2.74e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TDO2—autistic disorder	4.51e-06	2.72e-05	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—POMC—autistic disorder	4.49e-06	2.71e-05	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—HRAS—autistic disorder	4.48e-06	2.7e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—STX1A—autistic disorder	4.46e-06	2.69e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NPAS2—autistic disorder	4.46e-06	2.69e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	4.35e-06	2.62e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TCN2—autistic disorder	4.3e-06	2.59e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DHCR7—autistic disorder	4.24e-06	2.55e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ADSL—autistic disorder	4.22e-06	2.54e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—XDH—autistic disorder	4.14e-06	2.49e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ADA—autistic disorder	4.11e-06	2.47e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—STX1A—autistic disorder	4.06e-06	2.45e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NPAS2—autistic disorder	4.06e-06	2.45e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	4.06e-06	2.45e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—EXT1—autistic disorder	4.02e-06	2.42e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLC6A8—autistic disorder	4.02e-06	2.42e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TCN2—autistic disorder	3.92e-06	2.36e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	3.89e-06	2.34e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DAO—autistic disorder	3.83e-06	2.31e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—RORA—autistic disorder	3.74e-06	2.26e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ADA—autistic disorder	3.74e-06	2.26e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	3.7e-06	2.23e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—UPB1—autistic disorder	3.67e-06	2.21e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	3.54e-06	2.14e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MAOB—autistic disorder	3.51e-06	2.11e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTM5—autistic disorder	3.41e-06	2.06e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ASMT—autistic disorder	3.41e-06	2.06e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—RORA—autistic disorder	3.41e-06	2.06e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—autistic disorder	3.34e-06	2.01e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TPH2—autistic disorder	3.26e-06	1.97e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLC25A12—autistic disorder	3.21e-06	1.93e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DPYD—autistic disorder	3.21e-06	1.93e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MAOB—autistic disorder	3.2e-06	1.93e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SLC19A1—autistic disorder	3.12e-06	1.88e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	3.04e-06	1.83e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	3.01e-06	1.82e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CACNA1C—autistic disorder	2.98e-06	1.8e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TPH2—autistic disorder	2.97e-06	1.79e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DPYD—autistic disorder	2.93e-06	1.76e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.87e-06	1.73e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ADSL—autistic disorder	2.78e-06	1.68e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.75e-06	1.66e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—XDH—autistic disorder	2.73e-06	1.65e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CACNA1C—autistic disorder	2.72e-06	1.64e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DHFR—autistic disorder	2.71e-06	1.64e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NPAS2—autistic disorder	2.68e-06	1.61e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—STX1A—autistic disorder	2.68e-06	1.61e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.62e-06	1.58e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TCN2—autistic disorder	2.59e-06	1.56e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DHFR—autistic disorder	2.47e-06	1.49e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ADA—autistic disorder	2.47e-06	1.49e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.29e-06	1.38e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—RORA—autistic disorder	2.25e-06	1.36e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP19A1—autistic disorder	2.13e-06	1.28e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MAOB—autistic disorder	2.11e-06	1.27e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.09e-06	1.26e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2e-06	1.2e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—COMT—autistic disorder	1.98e-06	1.19e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTP1—autistic disorder	1.97e-06	1.19e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MAOA—autistic disorder	1.96e-06	1.18e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TPH2—autistic disorder	1.96e-06	1.18e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP19A1—autistic disorder	1.94e-06	1.17e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DPYD—autistic disorder	1.93e-06	1.16e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CAT—autistic disorder	1.91e-06	1.15e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.82e-06	1.1e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PLA2G4A—autistic disorder	1.81e-06	1.09e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTM1—autistic disorder	1.81e-06	1.09e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—COMT—autistic disorder	1.8e-06	1.09e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.79e-06	1.08e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTP1—autistic disorder	1.79e-06	1.08e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MAOA—autistic disorder	1.79e-06	1.08e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CAT—autistic disorder	1.75e-06	1.05e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GPX1—autistic disorder	1.73e-06	1.04e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PLA2G4A—autistic disorder	1.65e-06	9.93e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTM1—autistic disorder	1.65e-06	9.93e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DHFR—autistic disorder	1.63e-06	9.84e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MTHFR—autistic disorder	1.6e-06	9.63e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GPX1—autistic disorder	1.58e-06	9.51e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOE—autistic disorder	1.49e-06	8.96e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MTHFR—autistic disorder	1.46e-06	8.78e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOE—autistic disorder	1.36e-06	8.17e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PIK3CG—autistic disorder	1.34e-06	8.09e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP19A1—autistic disorder	1.28e-06	7.7e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—POMC—autistic disorder	1.28e-06	7.7e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PIK3CG—autistic disorder	1.22e-06	7.37e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—COMT—autistic disorder	1.19e-06	7.16e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTP1—autistic disorder	1.18e-06	7.13e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MAOA—autistic disorder	1.18e-06	7.11e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—POMC—autistic disorder	1.16e-06	7.02e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CAT—autistic disorder	1.15e-06	6.94e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PLA2G4A—autistic disorder	1.09e-06	6.55e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTM1—autistic disorder	1.09e-06	6.55e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GPX1—autistic disorder	1.04e-06	6.27e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PTGS2—autistic disorder	1.02e-06	6.14e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MTHFR—autistic disorder	9.61e-07	5.79e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PTGS2—autistic disorder	9.29e-07	5.6e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOE—autistic disorder	8.94e-07	5.39e-06	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PTEN—autistic disorder	8.89e-07	5.36e-06	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PTEN—autistic disorder	8.1e-07	4.88e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PIK3CG—autistic disorder	8.07e-07	4.86e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—POMC—autistic disorder	7.68e-07	4.63e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PTGS2—autistic disorder	6.13e-07	3.69e-06	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PTEN—autistic disorder	5.34e-07	3.22e-06	CbGpPWpGaD
